Gordon MacGregor

8.0k total citations
32 papers, 649 citations indexed

About

Gordon MacGregor is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Gordon MacGregor has authored 32 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Gordon MacGregor's work include Cystic Fibrosis Research Advances (21 papers), Neonatal Respiratory Health Research (6 papers) and Nematode management and characterization studies (3 papers). Gordon MacGregor is often cited by papers focused on Cystic Fibrosis Research Advances (21 papers), Neonatal Respiratory Health Research (6 papers) and Nematode management and characterization studies (3 papers). Gordon MacGregor collaborates with scholars based in United Kingdom, United States and Canada. Gordon MacGregor's co-authors include M. Imrie, A P Greening, David J. Porteous, Robert D. Gray, J. Alastair Innes, A. Christopher Boyd, Maria H Dewar, Donald Noble, Jaime Rubin and Conor Daly and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Gordon MacGregor

30 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon MacGregor United Kingdom 12 379 183 100 92 51 32 649
Raymond D. Coakley United States 14 812 2.1× 249 1.4× 301 3.0× 42 0.5× 127 2.5× 24 1.2k
Giorgia Radicioni United States 11 432 1.1× 264 1.4× 297 3.0× 27 0.3× 95 1.9× 17 909
Jen‐Shiu Chiang Chiau Taiwan 11 240 0.6× 384 2.1× 105 1.1× 38 0.4× 47 0.9× 16 726
Rachel A. Leslie United States 7 106 0.3× 157 0.9× 63 0.6× 42 0.5× 23 0.5× 10 742
Haihong Li China 13 576 1.5× 262 1.4× 55 0.6× 16 0.2× 45 0.9× 38 1.1k
Matthew R. Markovetz United States 13 507 1.3× 172 0.9× 85 0.8× 36 0.4× 56 1.1× 34 690
Maria Ansar United States 8 99 0.3× 101 0.6× 52 0.5× 63 0.7× 69 1.4× 13 447
Jacek Szeliga Poland 18 121 0.3× 157 0.9× 43 0.4× 252 2.7× 82 1.6× 51 1.1k
Michael D. Tsifansky United States 9 284 0.7× 94 0.5× 37 0.4× 90 1.0× 42 0.8× 14 518
Qiao Zhang China 12 81 0.2× 189 1.0× 108 1.1× 93 1.0× 60 1.2× 48 516

Countries citing papers authored by Gordon MacGregor

Since Specialization
Citations

This map shows the geographic impact of Gordon MacGregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon MacGregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon MacGregor more than expected).

Fields of papers citing papers by Gordon MacGregor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon MacGregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon MacGregor. The network helps show where Gordon MacGregor may publish in the future.

Co-authorship network of co-authors of Gordon MacGregor

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon MacGregor. A scholar is included among the top collaborators of Gordon MacGregor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon MacGregor. Gordon MacGregor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Jones, Joshua D., Helen J. Stacey, John W. Kennedy, et al.. (2024). How to: assess patient suitability for unlicensed phage therapy in the United Kingdom. Clinical Microbiology and Infection. 31(1). 57–61.
4.
MacGregor, Gordon, et al.. (2023). Ivacaftor: Five‐year outcomes in the West of Scotland cystic fibrosis population. The Clinical Respiratory Journal. 17(5). 473–477. 3 indexed citations
5.
Irvine, Michael A., et al.. (2023). EPS1.07 Impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on Aspergillus fumigatus serology in adults with cystic fibrosis. Journal of Cystic Fibrosis. 22. S39–S39. 1 indexed citations
6.
Cooper, David A., et al.. (2023). A Pharmacological Review of Calcitonin Gene-Related Peptide Biologics and Future Use for Chronic Pain. Cureus. 15(2). e35109–e35109. 3 indexed citations
7.
Daly, Conor, et al.. (2023). Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. Journal of Cystic Fibrosis. 22(4). 607–614. 69 indexed citations
8.
9.
Johnson, Chris, et al.. (2021). Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation. European Journal of Hospital Pharmacy. 30(3). 142–146. 3 indexed citations
10.
11.
Devereux, Graham, Stephen Bourke, Cori Daines, et al.. (2020). Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial. PLoS ONE. 15(12). e0242945–e0242945. 9 indexed citations
12.
Koningsbruggen‐Rietschel, Silke van, Jane C. Davies, Tacjana Pressler, et al.. (2020). Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study. ERJ Open Research. 6(4). 132–2020. 25 indexed citations
13.
Davies, Jane C., Silke van Koningsbruggen‐Rietschel, Gordon MacGregor, et al.. (2017). WS13.6 GLPG1837 in subjects with cystic fibrosis (CF) and the G551D mutation: results from a phase II study (SAPHIRA1). Journal of Cystic Fibrosis. 16. S24–S25. 4 indexed citations
14.
15.
Bayes, Hannah, Stephen Bicknell, Gordon MacGregor, & Tom Evans. (2014). T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis. PLoS ONE. 9(2). e90263–e90263. 36 indexed citations
16.
Gray, Robert D., Gordon MacGregor, Donald Noble, et al.. (2008). Sputum Proteomics in Inflammatory and Suppurative Respiratory Diseases. American Journal of Respiratory and Critical Care Medicine. 178(5). 444–452. 145 indexed citations
17.
MacGregor, Gordon, Robert D. Gray, M. Imrie, et al.. (2008). Biomarkers for cystic fibrosis lung disease: Application of SELDI-TOF mass spectrometry to BAL fluid. Journal of Cystic Fibrosis. 7(5). 352–358. 36 indexed citations
18.
Griesenbach, Uta, Chris Kitson, Raymond Farley, et al.. (2006). Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respiratory Research. 7(1). 26–26. 49 indexed citations
19.
Davidson, Heather, Gerry McLachlan, A. Christopher Boyd, et al.. (2006). Human-Specific Cystic Fibrosis Transmembrane Conductance Regulator Antibodies Detect In Vivo Gene Transfer to Ovine Airways. American Journal of Respiratory Cell and Molecular Biology. 35(1). 72–83. 7 indexed citations
20.
MacGregor, Gordon, Samantha Ellis, James Andrews, et al.. (2005). Breath condensate ammonium is lower in children with chronic asthma. European Respiratory Journal. 26(2). 271–276. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond D. Coakley Breakdown of academic impact, for papers by Giorgia Radicioni Breakdown of academic impact, for papers by Jen‐Shiu Chiang Chiau Breakdown of academic impact, for papers by Rachel A. Leslie Breakdown of academic impact, for papers by Haihong Li Breakdown of academic impact, for papers by Matthew R. Markovetz Breakdown of academic impact, for papers by Maria Ansar Breakdown of academic impact, for papers by Jacek Szeliga Breakdown of academic impact, for papers by Michael D. Tsifansky Breakdown of academic impact, for papers by Qiao Zhang
Rankless by CCL
2026